Vitamin D: Marker or mechanism of action?

Elizabeth T Jacobs, María Elena Martínez, Peter W. Jurutka

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The field of vitamin D and cancer research has been moving forward quickly. However, some challenges remain regarding the interpretation and integration of data collected from epidemiological investigations and laboratory experiments. These include consideration of vitamin D biology, a better understanding of characteristics that affect concentrations of the biomarker of vitamin D status, 25(OH)D, and elucidation of variation in response to vitamin D supplementation. To further the field of vitamin D and cancer prevention, future studies will need to bridge the gap between the epidemiology and molecular biology of vitamin D activity in carcinogenesis.

Original languageEnglish (US)
Pages (from-to)585-590
Number of pages6
JournalCancer Epidemiology Biomarkers and Prevention
Volume20
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Vitamin D
Molecular Biology
Neoplasms
Carcinogenesis
Epidemiology
Biomarkers
Research

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Vitamin D : Marker or mechanism of action? / Jacobs, Elizabeth T; Martínez, María Elena; Jurutka, Peter W.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 20, No. 4, 04.2011, p. 585-590.

Research output: Contribution to journalArticle

Jacobs, Elizabeth T ; Martínez, María Elena ; Jurutka, Peter W. / Vitamin D : Marker or mechanism of action?. In: Cancer Epidemiology Biomarkers and Prevention. 2011 ; Vol. 20, No. 4. pp. 585-590.
@article{9ddeea4da0774d80a8caf3867f342b0d,
title = "Vitamin D: Marker or mechanism of action?",
abstract = "The field of vitamin D and cancer research has been moving forward quickly. However, some challenges remain regarding the interpretation and integration of data collected from epidemiological investigations and laboratory experiments. These include consideration of vitamin D biology, a better understanding of characteristics that affect concentrations of the biomarker of vitamin D status, 25(OH)D, and elucidation of variation in response to vitamin D supplementation. To further the field of vitamin D and cancer prevention, future studies will need to bridge the gap between the epidemiology and molecular biology of vitamin D activity in carcinogenesis.",
author = "Jacobs, {Elizabeth T} and Mart{\'i}nez, {Mar{\'i}a Elena} and Jurutka, {Peter W.}",
year = "2011",
month = "4",
doi = "10.1158/1055-9965.EPI-10-1257",
language = "English (US)",
volume = "20",
pages = "585--590",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Vitamin D

T2 - Marker or mechanism of action?

AU - Jacobs, Elizabeth T

AU - Martínez, María Elena

AU - Jurutka, Peter W.

PY - 2011/4

Y1 - 2011/4

N2 - The field of vitamin D and cancer research has been moving forward quickly. However, some challenges remain regarding the interpretation and integration of data collected from epidemiological investigations and laboratory experiments. These include consideration of vitamin D biology, a better understanding of characteristics that affect concentrations of the biomarker of vitamin D status, 25(OH)D, and elucidation of variation in response to vitamin D supplementation. To further the field of vitamin D and cancer prevention, future studies will need to bridge the gap between the epidemiology and molecular biology of vitamin D activity in carcinogenesis.

AB - The field of vitamin D and cancer research has been moving forward quickly. However, some challenges remain regarding the interpretation and integration of data collected from epidemiological investigations and laboratory experiments. These include consideration of vitamin D biology, a better understanding of characteristics that affect concentrations of the biomarker of vitamin D status, 25(OH)D, and elucidation of variation in response to vitamin D supplementation. To further the field of vitamin D and cancer prevention, future studies will need to bridge the gap between the epidemiology and molecular biology of vitamin D activity in carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=79955770003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955770003&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-10-1257

DO - 10.1158/1055-9965.EPI-10-1257

M3 - Article

C2 - 21454423

AN - SCOPUS:79955770003

VL - 20

SP - 585

EP - 590

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 4

ER -